No Detail Found!

Correlation of HER2 Expression in Gastric Carcinoma with Clinicopathological Parameters in the Omani Population

Author(s)
Asim Qureshi Department of Pathology, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman
Hana Al Julandana College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman
Sara Al Barkhati Department of Pathology, College of Medicine, Mansoura University, Mansoura, Egypt
Ahmed Al Ghaithi College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman
Asem Shalaby Department of Pathology, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman;Department of Pathology, College of Medicine, Mansoura University, Mansoura, Egypt
Abstract
This retrospective study was conducted to determine the relation between human epidermal growth factor receptor 2 (HER2) expression and the clinicopathological and prognostic characteristics of gastric cancer (GC) patients treated at theDepartment of Pathology, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman. It included 49 patients diagnosed with GC and treated between 2018 and 2021. The positivity rate for HER2 was 24.4%, but no signi cant correlation was found between HER2 expression and tumour histological grade (p = 0.577), presence of metastasis (p = 0.935), or histopathological type (p = 0.531). Furthermore, there was no statistically signi cant di erence in survival rates between patients who received Herceptin (immune-targeted therapy also known as trastuzumab) and those who did not, despite having positive HER2 expression (p = 0.826). No signi cant correlation was observed between the examined parameters and HER2 expression status.
Publication Details
Page(s) 929-931
Published Journal: Journal of the College of Physicians and Surgeons Pakistan, Volume: 35, Issue: 07, Year: 2025

Request the full text from PASTIC

Keywords
Clinical, Gastric cancer, HER2, Pathological parameters
References
Wu S,Xu P .2023 .Advances in targeted therapy for gastric cancer based on tumour driver genes. Zhejiang Da Xue Xue Bao Yi Xue Ban, 10(1) : 73-83.
Hasan R,Bhatt D,Khan S,Khan V,Verma AK,Anees A .2019 .Association of HER2 expression and clinicopathological parameters in colorectal carcinoma in Indian population. Open Access Maced J Med Sci, 008(1) : 6-11.
Wang HB,Liao XF,Zhang J .2017 .Clinicopathological factors associated with HER2-positive gastric cancer: A metaanalysis. Medicine, 10(44) : .
0

Citations

0

Downloads

122

Views